Category: Database

TRIM21

TRIM21 is a unique intracellular antibody receptor and RING finger ubiquitin ligase that neutralises antibody‑coated viruses inside the cytosol. Through its PRY/SPRY domain and tripartite motif, TRIM21 triggers rapid ubiquitin‑mediated degradation and activates antiviral signalling pathways. Its roles in immunity, autoimmunity and biotechnology make TRIM21 a key regulator of intracellular defence.

TRIM25

TRIM25 is a RING finger ubiquitin ligase that activates the antiviral sensor RIG‑I through K63‑linked ubiquitination. Its tripartite motif and PRY/SPRY domain enable precise regulation of innate immune signalling, interferon production and viral restriction. TRIM25 is targeted by multiple viruses, highlighting its importance as a frontline antiviral factor.

TRIM Family

The TRIM family is a large group of single‑chain RING finger ubiquitin ligases that regulate innate immunity, antiviral defence, autophagy, transcription and protein quality control. Defined by their tripartite motif—RING, B‑box and coiled‑coil domains—TRIM proteins use diverse C‑terminal regions to achieve precise substrate specificity. Their roles in immunity, development and cancer make them key regulators of cellular homeostasis.

Cbl‑c

Cbl‑c is an epithelial‑specific RING finger ubiquitin ligase that regulates EGFR and other receptor tyrosine kinases through targeted ubiquitination. With a streamlined domain architecture and restricted expression pattern, Cbl‑c maintains epithelial homeostasis and prevents excessive RTK signalling. Loss or mutation of Cbl‑c contributes to epithelial cancers, highlighting its importance in growth control and oncogenesis.

Cbl‑b

Cbl‑b is a single‑chain RING finger ubiquitin ligase that acts as a master regulator of immune activation. By ubiquitinating key signalling molecules in T‑cells, B‑cells and NK cells, Cbl‑b maintains immune tolerance and prevents hyperactivation. Loss of Cbl‑b leads to autoimmunity and enhanced anti‑tumour immunity, making it a critical player in immune homeostasis and a promising target in cancer immunotherapy.

CBL Family Ubiquitin Ligase

The CBL family of ubiquitin ligases—c‑Cbl, Cbl‑b and Cbl‑c—are single‑chain RING finger E3 enzymes that regulate receptor tyrosine kinase signalling, immune activation and epithelial homeostasis. Through their TKB and RING domains, CBL proteins control ubiquitination, endocytosis and signal attenuation. Dysregulation of CBL ligases contributes to cancer, autoimmunity and inflammatory disorders, highlighting their importance in cellular regulation and disease.

c‑Cbl

c‑Cbl is a single‑chain RING finger ubiquitin ligase that regulates receptor tyrosine kinase signalling by binding phosphorylated RTKs and catalysing their ubiquitination. Through its TKB domain and RING domain, c‑Cbl controls EGFR turnover, immune signalling and cell growth. Mutations in c‑Cbl disrupt ubiquitination and contribute to myeloid malignancies, highlighting its importance in cellular homeostasis and disease.

Hutchinson–Gilford Progeria Syndrome

Hutchinson–Gilford progeria syndrome is a rare genetic disorder caused by LMNA mutations that generate progerin, a toxic protein disrupting nuclear structure and accelerating ageing. Children develop rapid cardiovascular decline, growth failure and systemic tissue deterioration, making HGPS one of the most important models for understanding human ageing.

Laminopathy

A laminopathy is a disorder caused by mutations in genes encoding nuclear‑lamina proteins, most notably LMNA, which produces lamin A…

Mdm2 (Mouse Double Minute 2 Homologue)

Mdm2 is a RING‑type E3 ubiquitin ligase that controls p53 stability through ubiquitination, nuclear export and proteasomal degradation. By interacting with p53, Mdmx/Mdm4 and ARF, Mdm2 regulates DNA‑damage responses, cell‑cycle progression and oncogenesis, making it a central determinant of tumour development and genome stability.

Sertoli Cell‑Only Syndrome

Sertoli‑cell‑only syndrome is a severe testicular disorder in which seminiferous tubules contain only Sertoli cells and no germ cells. Caused by AZFa microdeletions, germ‑cell developmental gene mutations or acquired testicular injury, SCOS represents an advanced form of non‑obstructive azoospermia with major implications for fertility and genetic counselling.

Cdc25

Cdc25 phosphatases activate CDKs to drive both the G1–S and G2–M transitions. By removing inhibitory phosphates from CDK1 and CDK2, Cdc25 triggers DNA replication and mitotic entry. Checkpoint kinases such as Chk1 inhibit Cdc25 during DNA damage, while Cdc25 overexpression promotes genomic instability and contributes to tumour progression.

Retinoblastoma Protein (pRb)

pRb is a major tumour‑suppressor that governs the G1–S transition by restraining E2F transcription factors and maintaining a repressive chromatin state. When pRb becomes hyperphosphorylated, cells commit to DNA replication. Loss of pRb function leads to uncontrolled proliferation, replication stress and genomic instability, making it a key player in cancer development.

Cdh1

Cdh1 is a major activator of the APC/C complex, responsible for mitotic exit, G1 maintenance and replication licensing. By degrading Cyclin B, Aurora A, Plk1 and Geminin, Cdh1 prevents premature S‑phase entry and maintains genomic stability. Its dysregulation contributes to replication stress, chromosomal instability and cancer development.

Cdc20

Cdc20 is a key activator of the APC/C complex, initiating the metaphase‑to‑anaphase transition by promoting securin and Cyclin B degradation. Regulated by checkpoint proteins such as Mad2 and BubR1, Cdc20 safeguards chromosome segregation, while its dysregulation contributes to aneuploidy and cancer progression.